Mergers & Acquisitions
By The Online Investor Staff, updated Thu., Feb. 27, 3:43 PM
| This Slide: #63 of 100 |
Slide #63. Roche — Promedior, Inc.
Acquirer:
Roche (RHHBY)
Acquiree:
Promedior, Inc.
Details:
Promedior, Inc. today announced the successful completion of its previously announced sale to Roche (SIX: RO, ROG; OTCQX: RHHBY). With this acquisition, Roche obtained full rights to Promedior's entire portfolio of molecules for serious fibrotic diseases, notably PRM-151. Under the terms of the merger agreement, Roche made an upfront cash payment of USD 390 million, with additional contingent payments of up to USD 1 billion to be made based on the achievement of certain predetermined development, regulatory and commercial milestones.
Promedior, Inc. : PRIVATE
Open the TOCA Page at The Online Investor (in a new window) »
|
|
Avg. Broker Rec.
 
|
Hold (2.00 out of 4) 0th percentile
(ranked lower than approx. 100% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |
